Your browser doesn't support javascript.
loading
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Niciu, Mark J; Iadarola, Nicolas D; Banerjee, Dipavo; Luckenbaugh, David A; Park, Minkyung; Lener, Marc; Park, Lawrence; Ionescu, Dawn F; Ballard, Elizabeth D; Brutsche, Nancy E; Akula, Nirmala; McMahon, Francis J; Machado-Vieira, Rodrigo; Nugent, Allison C; Zarate, Carlos A.
Afiliação
  • Niciu MJ; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Iadarola ND; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Banerjee D; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Luckenbaugh DA; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Park M; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Lener M; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Park L; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Ionescu DF; 2 Depression Clinical and Research Program, Massachusetts General Hospital, Boston, USA.
  • Ballard ED; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Brutsche NE; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Akula N; 3 Human Genetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • McMahon FJ; 3 Human Genetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Machado-Vieira R; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Nugent AC; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
  • Zarate CA; 1 Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA.
J Psychopharmacol ; 31(12): 1570-1577, 2017 12.
Article em En | MEDLINE | ID: mdl-29039254
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Complementares: Homeopatia Assunto principal: Fator Neurotrófico Derivado do Encéfalo / Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Clinical_trials Idioma: En Revista: J Psychopharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Complementares: Homeopatia Assunto principal: Fator Neurotrófico Derivado do Encéfalo / Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Ketamina Tipo de estudo: Clinical_trials Idioma: En Revista: J Psychopharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos